In TOMORROW’s GEN webinar, Mu-ming Poo, PhD, Miguel Esteban, PhD, and Jan Mulder will discuss some of the wide-ranging applications of spatial technology using examples that demonstrate the technology’s ability to provide a more fine-grained picture of cells’ underlying molecular mechanisms in areas such as digital pathology and developmental biology.
In this GEN webinar, a panel of industry experts will explore the evolution of mRNA technology and the innovations that are driving the conversation around manufacturing setups and regulatory decisions.
In this GEN webinar, Jin Lu, PhD, discusses latest additions to the GS® expression toolbox and shares strategies for using these technologies to drive successful development of your molecule from discovery through to commercial supply.
In this GEN webinar, Troy Ostreng will discuss CPC’s suite of connector solutions for addressing sterility, chemical compatibility, and ultra-low temperature challenges in the CGT development process, and how they ensure long-term success.
In this inaugural GEN chat webinar, Rade Drmanac, PhD, sat down with Dr. Julianna LeMieux (Deputy Editor in Chief, GEN) for a candid conversation about all things next-gen sequencing (NGS).
In this GEN webinar, Mark Frohlich, MD, CEO of Indapta Therapeutics, discussed the company’s approach to developing a universal, allogeneic g-NK cell therapy that improves the cytotoxicity of antibody therapy in cancer.
In this GEN webinar, our speakers Xiaoyue Chenn, PhD, and Yifeng Li, PhD, will present WuXi Biologics’ suite of advanced solutions for overcoming obstacles associated with the development and manufacturing of complex biologics.
In this GEN webinar, Robert Bowman, PhD, from the Perelman School of Medicine will discuss his lab’s approaches for modeling clonal evolution in mouse models of disease.
In this GEN webinar, our speakers Xiaoping Zeng He, PhD, and Chris Heger, PhD, will discuss icIEF technology and its application to protein charge analysis in AAV gene therapy development.
In this GEN webinar, Tavotek Biotherapeutics’ CSO Mark Chiu, PhD, will present a process for selecting an EGFR x cMET bispecific antibody to treat patients with EGFR inhibitor-resistant non-small lung cancer.
In this GEN Learning Lab, CN Bio’s CSO Tomasz Kostrzewski, PhD, and toxicology consultant Clive Roper, PhD, will discuss all things OOC, including current applications, the evolving perspective of regulators, and ongoing efforts to harness OOCs’ potential in biomedicine.
In this GEN webinar, Ben Peacock, PhD, will present the NanoAnalyzer platform and describe how it supports multi-parameter analysis and characterization of biological nanoparticles like LNPs.
